The company beat market estimates for fourth-quarter results today, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs pipeline, underscoring the benefits of its consumer health unit spin-off.
Tag Archive for: GSK
The British drugmaker said it sold around 300 million shares of Haleon, cutting its shareholding to 4.2%, as it expands its portfolio of specialty medicines.
Following the J.P. Morgan Healthcare Conference and other parallel meetings in San Francisco, it’s time to reflect on some of the significant deals secured last week.
Aiolos focuses on therapies for respiratory and inflammatory conditions, and is currently developing ‘AIO-001’, a treatment for asthma which is ready to enter mid-stage clinical trials.
The company announced that a combination of its cancer drugs Zejula and Jemperli, when as used as a maintenance therapy following Jemperli plus chemotherapy, met the main goal of a late-stage trial to treat a certain type of endometrial cancer.
The European health regulator cited recent data that did not confirm the blood cancer drug’s effectiveness.
CEO Emma Walmsley projects that the British biopharma’s Arexvy sales will exceed £1 billion in its first year on the market, leaving Pfizer’s Abrysvo respiratory syncytial virus vaccine far behind in the race.
GSK said on that its blood cancer drug Blenrep had reached a key goal in a late-stage trial, as the British drugmaker looks to bolster its oncology business after a series of setbacks.
A batch of 331,200 doses of the vaccine – also known as RTS,S – was offloaded at Yaounde’s Nsimalen International Airport, making Cameroon the first African country to receive the vaccine after the pilot programs in Ghana, Kenya and Malawi.
The company said that the marketing authorization decision could come early next year.
